Tag: EDP2939
Evelo Biosciences Presents New Preclinical Data for Extracellular Vesicle Anti-inflammatory Product...
–On-track to initiate clinical development of EDP2939 in 2022– CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc....